Etid klinik pou Psoryaz nan Indiana
4 etid pou Psoryaz ap chèche patisipan nan sit nan Indiana.
Vil nan Indiana
Tèks ofisyèl etid la (Anglè)
Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
- Vanda Investigational Site, Indianapolis
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Sep 22, 2026 · NCT07362017A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
- The Indiana Clinical Trials Center, PC, Plainfield
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06857942A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
Ap rekriteFaz 3
Laj 12 a 17 · Tout sèks · Mizajou Sep 3, 2026 · NCT06979453A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
- Study Center, Clarksville
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Jul 9, 2026 · NCT07489885Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.